




Searching News Database: diabetic nephropathy
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
HSMN NewsFeed - 7 Apr 2008
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 10 May 2006
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
Additional items found! 29

Members Archive contains
29 additional stories matching:
diabetic nephropathy
(Password required)
diabetic nephropathy
(Password required)